<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="relies on deletion of the essential HA gene from the" exact="viral" post="genome and its provision by a genetically modified cell"/>
 <result pre="pathogens, including gain-of-function variants, without the risk of generating fully" exact="infectious" post="viruses. Furthermore, we demonstrate that this system can be"/>
 <result pre="antiviral strategies. Abstract ABSTRACT Natural adaptation of an antigenically novel" exact="avian influenza" post="A virus (IAV) to be transmitted efficiently in humans"/>
 <result pre="humans has the potential to trigger a devastating pandemic. Understanding" exact="viral" post="genetic determinants underlying adaptation is therefore critical for pandemic"/>
 <result pre="this work has risks, as making gain-of-function substitutions in fully" exact="infectious" post="IAVs may create a pathogen with pandemic potential. Thus,"/>
 <result pre="H5N1 strain. The system relies on deletion of the essential" exact="viral" post="hemagglutinin (HA) gene, which is instead provided in trans,"/>
 <result pre="of HA, a Renilla luciferase gene is inserted within the" exact="viral" post="genome, and a live-cell luciferase substrate allows real-time quantitative"/>
 <result pre="and a live-cell luciferase substrate allows real-time quantitative monitoring of" exact="viral" post="replication kinetics with a high dynamic range. We demonstrate"/>
 <result pre="relies on deletion of the essential HA gene from the" exact="viral" post="genome and its provision by a genetically modified cell"/>
 <result pre="pathogens, including gain-of-function variants, without the risk of generating fully" exact="infectious" post="viruses. Furthermore, we demonstrate that this system can be"/>
 <result pre="word-count: INTRODUCTION Seasonal influenza A viruses (IAV) can cause an" exact="acute" post="respiratory illness in humans, with symptoms including fever, dry"/>
 <result pre="INTRODUCTION Seasonal influenza A viruses (IAV) can cause an acute" exact="respiratory" post="illness in humans, with symptoms including fever, dry cough,"/>
 <result pre="illness in humans, with symptoms including fever, dry cough, headache," exact="muscle" post="pain, and malaise. The disease is typically mild and"/>
 <result pre="including fever, dry cough, headache, muscle pain, and malaise. The" exact="disease" post="is typically mild and self-resolving, but it can be"/>
 <result pre="groups, such as young children, the elderly, and those with" exact="chronic" post="underlying health conditions or an immunosuppressed state. Therefore, annual"/>
 <result pre="humans and can cause critical disease, such as severe pneumonia," exact="acute" post="respiratory distress syndrome, and significant fatalities, even in young,"/>
 <result pre="and can cause critical disease, such as severe pneumonia, acute" exact="respiratory" post="distress syndrome, and significant fatalities, even in young, otherwise"/>
 <result pre="For example, avian H5N1 IAVs have caused 861 recorded human" exact="infections" post="and 455 deaths since 2003, while avian H7N9 IAVs"/>
 <result pre="since 2003, while avian H7N9 IAVs have caused &amp;gt;1,500 human" exact="infections" post="since 2013 (2). The fear is that one of"/>
 <result pre="permit them to replicate, to be transmitted, and to cause" exact="disease" post="in humans. Such work allows the identification of sequence"/>
 <result pre="studies in this area identified several amino acid substitutions in" exact="viral" post="proteins, notably hemagglutinin (HA), that are critical for allowing"/>
 <result pre="and biosecurity frameworks (37â€&quot;41). Biologically contained viruses, where an essential" exact="viral" post="gene is deleted from a pathogen and is expressed"/>
 <result pre="to study highly pathogenic viruses such as Ebola virus and" exact="Omsk hemorrhagic fever" post="virus safely at lower containment levels than their usual"/>
 <result pre="as Ebola virus and Omsk hemorrhagic fever virus safely at" exact="lower" post="containment levels than their usual biosafety level 4 (BSL4)"/>
 <result pre="up a range of valuable experimental activities due to the" exact="lower" post="associated operating costs, increased equipment availability, and number of"/>
 <result pre="that can use them. Often, in these methods, the essential" exact="viral" post="gene is replaced with a convenient reporter gene, such"/>
 <result pre="assess the applicability of a biologically contained IAV concept, with" exact="viral" post="deletion of HA (45), to strains such as highly"/>
 <result pre="can undergo multicycle replication (45) but are restricted to single-cycle" exact="infections" post="in cells lacking expression of a complementing HA molecule"/>
 <result pre="the polybasic cleavage site (termed HALo) (47), and verified their" exact="stable" post="expression by Western blotting (Fig.Â 1C). Indirect immunofluorescence also"/>
 <result pre="expression of the respective HA and that all HAs predominantly" exact="localized" post="to the cell surface (Fig.Â 1D). Using these cell"/>
 <result pre="of final virus titers on MDCK cells (nâ€‰=â€‰3) following three" exact="blind" post="passages on MDCK cells (i.e., transferring half the supernatant"/>
 <result pre="supernatant to fresh cells every 48 h) after an initial" exact="infection" post="at an MOI of 0.001 PFU/cell. (G) Relative levels"/>
 <result pre="or Viet/04-Renilla IAV-like particles at a range of multiplicities of" exact="infection" post="(MOI) and added EnduRen substrate to the medium at"/>
 <result pre="to perform direct live-cell luminescence readouts every 3â€‰h until the" exact="viral" post="replication kinetics were complete (Fig.Â 2A to F). Notably,"/>
 <result pre="luminescence readouts every 3â€‰h until the viral replication kinetics were" exact="complete" post="(Fig.Â 2A to F). Notably, in preliminary experiments we"/>
 <result pre="in preliminary experiments we found that the EnduRen substrate is" exact="stable" post="in tissue culture medium for at least 30â€‰h and"/>
 <result pre="need to be replenished. Relatively high-MOI (1 and 0.1 PFU/cell)" exact="infections" post="of MDCK or MDCK-HA cells with all of the"/>
 <result pre="to F). In contrast, relatively low-MOI (0.01 and 0.001 PFU/cell)" exact="infections" post="showed peak luminescence levels only âˆ¼10- to 100-fold above"/>
 <result pre="luminescence levels only âˆ¼10- to 100-fold above that of mock" exact="infection" post="in MDCK cells lacking HA expression (Fig.Â 2A, C,"/>
 <result pre="HA expression (Fig.Â 2A, C, and E), suggesting only single-cycle" exact="infections" post="in these cells, but led to luminescence levels âˆ¼1,000-fold"/>
 <result pre="cells, but led to luminescence levels âˆ¼1,000-fold higher than mock" exact="infection" post="at later time points (12 to 24 h postinfection)"/>
 <result pre="range. FIGÂ 2 Live-cell kinetic analysis of single-cycle and multicycle" exact="infections" post="with the biologically contained IAV reporters expressing Renilla luciferase."/>
 <result pre="viruses, making them a useful surrogate when work with fully" exact="infectious" post="IAVs has to be limited. We further profiled the"/>
 <result pre="the antiviral activity of baloxavir, a potent inhibitor of the" exact="viral" post="endonuclease (49), against all of our IAV-Renilla reporters. MDCK"/>
 <result pre="For example, genetic engineering of species-specific microRNA target sites into" exact="viral" post="genomes can limit replication exclusively to nonhuman experimental models"/>
 <result pre="major advantage would be the sensitive reporter read-out at a" exact="lower" post="physical biocontainment level (e.g., BSL2). Importantly, in such a"/>
 <result pre="and lowers the pH required for fusion (11, 53, 57)." exact="Stable" post="homogenous expression and correct localization of the Viet/04-T-HA protein"/>
 <result pre="against Viet/04-T-Renilla IAV as it is against Viet/04-Renilla IAV during" exact="infection" post="(Fig.Â 5C). In addition, we tested the neutralization capabilities"/>
 <result pre="each antibody or serum at various concentrations prior to single-cycle" exact="infection" post="of MDCK cells. Following addition of EnduRen, luciferase activity"/>
 <result pre="inhibition, were calculated using the nonlinear regression curve for each" exact="infection" post="(Fig.Â 5D and E). Importantly, Viet/04-T-Renilla IAV was sensitive"/>
 <result pre="of Viet/04-Renilla or Viet/04-T-Renilla IAV for 1 h prior to" exact="infection" post="of MDCK cells and addition of EnduRen substrate. Luminescence"/>
 <result pre="no possibility of its being genetically incorporated into a fully" exact="infectious" post="virus, is the essential feature, as IAVs with novel"/>
 <result pre="and Viet/04) or by commercial gene synthesis (Viet/04-T; GeneArt; Thermo" exact="Fisher" post="Scientific). Both Viet/04-derived HA constructs lacked the sequence encoding"/>
 <result pre="days later, transduced cells were selected with puromycin (3.5â€‰Î¼g/ml; Thermo" exact="Fisher" post="Scientific) and subcloned by limiting dilution. Clonal cell colonies"/>
 <result pre="(1:500; 19D3 [60]), or Î²-actin (no. sc-47778; Santa Cruz). The" exact="secondary" post="antibody used was a fluorochrome-conjugated anti-mouse immunoglobulin (no. 35519;"/>
 <result pre="antibody used was a fluorochrome-conjugated anti-mouse immunoglobulin (no. 35519; Thermo" exact="Fisher" post="Scientific). A Li-Cor Odyssey scanner was used for detection"/>
 <result pre="no. 200-301-976; Rockland), or Neth/09 HA (1:500; 19D3 [60]). The" exact="secondary" post="antibodies used were Alexa Fluor-conjugated donkey anti-mouse and -rabbit"/>
 <result pre="in 96-well plates were washed once with PBS prior to" exact="infections" post="with the different viruses at the appropriate MOI in"/>
 <result pre="(no. 2705; BEI Resources) at 4Â°C for 1 h before" exact="infection" post="of cells. Also where noted, the indicated concentrations of"/>
 <result pre="or a Dynex MLX luminometer (Dynex Technologies). All experiments included" exact="infection" post="of multiple wells for technical replicates, and each experiment"/>
 <result pre="StevensJ, TumpeyTM, GubarevaLV, KatzJM, VillanuevaJM, DonisRO, CoxNJ2014Use of highly pathogenic" exact="avian influenza" post="A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness."/>
 <result pre="MaherEA, NeumannG, KawaokaY2012Experimental adaptation of an influenza H5 HA confers" exact="respiratory" post="droplet transmission to a reassortant H5 HA/H1N1 virus in"/>
 <result pre="for a science-based discussion. mBio5:e01730-14. doi:10.1128/mBio.01730-14.25085113 25.Wain-HobsonS2014The irrationality of GOF" exact="avian influenza" post="virus research. Front Public Health2:77. doi:10.3389/fpubh.2014.00077.25077136 26.Wain-HobsonS2013Pandemic influenza viruses:"/>
 <result pre="of risk and elapsed time for escape of a laboratory-acquired" exact="infection" post="from his laboratory. mBio6:e00268-15. doi:10.1128/mBio.00268-15.25873376 30.FouchierRA2015Reply to â€œComments on"/>
 <result pre="of risk and elapsed time for escape of a laboratory-acquired" exact="infection" post="from his laboratory.â€� mBio6:e00407-15. doi:10.1128/mBio.00407-15.25873379 31.LipsitchM2014Can limited scientific value"/>
 <result pre="of a laboratory-acquired infection from his laboratory.â€� mBio6:e00407-15. doi:10.1128/mBio.00407-15.25873379 31.LipsitchM2014Can" exact="limited" post="scientific value of potential pandemic pathogen experiments justify the"/>
 <result pre="TashiroM, TaubenbergerJK, ThomasPG, TrippRA, TumpeyTM, WebbyRJ, WebsterRG2013Transmission studies resume for" exact="avian flu." post="Science339:520â€&quot;521. doi:10.1126/science.1235140.23345603 34.FouchierRA, Garcia-SastreA, KawaokaY, BarclayWS, BouvierNM, BrownIH, CapuaI,"/>
 <result pre="SwayneDE, TakimotoT, TashiroM, TaubenbergerJK, ThomasPG, TrippRA, TumpeyTM, WebbyRJ, WebsterRG2012Pause on" exact="avian flu" post="transmission research. Science335:400â€&quot;401. doi:10.1126/science.335.6067.400.22282787 35.FouchierRA, Garcia-SastreA, KawaokaY2012Pause on avian"/>
 <result pre="avian flu transmission research. Science335:400â€&quot;401. doi:10.1126/science.335.6067.400.22282787 35.FouchierRA, Garcia-SastreA, KawaokaY2012Pause on" exact="avian flu" post="transmission studies. Nature481:443. doi:10.1038/481443a. 36.LipsitchM, InglesbyTV2014Moratorium on research intended"/>
 <result pre="use research of concern. J Virol88:6535â€&quot;6537. doi:10.1128/JVI.00875-14.24696484 39.LipkinWI2012Biocontainment in gain-of-function" exact="infectious disease" post="research. mBio3:e00290-12. doi:10.1128/mBio.00290-12. 40.FouchierRA, Garcia-SastreA, KawaokaY2012The pause on Avian"/>
 <result pre="research of concern. J Virol88:6535â€&quot;6537. doi:10.1128/JVI.00875-14.24696484 39.LipkinWI2012Biocontainment in gain-of-function infectious" exact="disease" post="research. mBio3:e00290-12. doi:10.1128/mBio.00290-12. 40.FouchierRA, Garcia-SastreA, KawaokaY2012The pause on Avian"/>
 <result pre="infectious disease research. mBio3:e00290-12. doi:10.1128/mBio.00290-12. 40.FouchierRA, Garcia-SastreA, KawaokaY2012The pause on" exact="Avian" post="H5N1 influenza virus transmission research should be ended. mBio3:e00358-12."/>
 <result pre="LiN, DengC, ZhangZ, LiX, YoshiiK, YeH, ZhangB2019Trans complementation of replication-defective" exact="Omsk hemorrhagic fever" post="virus for antiviral study. Virol Sin34:412â€&quot;422. doi:10.1007/s12250-019-00109-0.30949960 44.NogalesA, BakerSF,"/>
 <result pre="Sin34:412â€&quot;422. doi:10.1007/s12250-019-00109-0.30949960 44.NogalesA, BakerSF, DommW, Martinez-SobridoL2016Development and applications of single-cycle" exact="infectious" post="influenza A virus (sciIAV). Virus Res216:26â€&quot;40. doi:10.1016/j.virusres.2015.07.013.26220478 45.MarshGA, HatamiR,"/>
 <result pre="45.MarshGA, HatamiR, PaleseP2007Specific residues of the influenza A virus hemagglutinin" exact="viral" post="RNA are important for efficient packaging into budding virions."/>
 <result pre="containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic" exact="avian influenza." post="J Virol83:1742â€&quot;1753. doi:10.1128/JVI.01920-08.19073731 48.CloseDM, HahnRE, PattersonSS, BaekSJ, RippSA, SaylerGS2011Comparison"/>
 <result pre="doi:10.1128/JVI.01920-08.19073731 48.CloseDM, HahnRE, PattersonSS, BaekSJ, RippSA, SaylerGS2011Comparison of human optimized" exact="bacterial" post="luciferase, firefly luciferase, and green fluorescent protein for continuous"/>
 <result pre="de HaanCA, WilsonIA, PaulsonJC2014Hemagglutinin receptor specificity and structural analyses of" exact="respiratory" post="droplet-transmissible H5N1 viruses. J Virol88:768â€&quot;773. doi:10.1128/JVI.02690-13.24173215 54.ChutinimitkulS, van RielD,"/>
 <result pre="viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by" exact="respiratory" post="droplet. Science340:1459â€&quot;1463. doi:10.1126/science.1229455.23641061 57.XiongX, CoombsPJ, MartinSR, LiuJ, XiaoH, McCauleyJW,"/>
 <result pre="WalkerPA, CollinsPJ, KawaokaY, SkehelJJ, GamblinSJ2013Receptor binding by a ferret-transmissible H5" exact="avian influenza" post="virus. Nature497:392â€&quot;396. doi:10.1038/nature12144.23615615 58.WhiteKM, De JesusP, ChenZ, AbreuPJr, BarileE,"/>
</results>
